Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, Par Value $0.01 per share
-
Shares outstanding
-
162,190,120
-
Number of holders
-
412
-
Total 13F shares, excl. options
-
37,367,414
-
Shares change
-
-2,500,447
-
Total reported value, excl. options
-
$7,745,430,573
-
Value change
-
-$523,926,966
-
Put/Call ratio
-
127%
-
Number of buys
-
237
-
Number of sells
-
-150
-
Price
-
$207.31
Significant Holders of NOVAVAX INC - Common Stock, Par Value $0.01 per share (NVAX) as of Q3 2021
514 filings reported holding NVAX - NOVAVAX INC - Common Stock, Par Value $0.01 per share as of Q3 2021.
NOVAVAX INC - Common Stock, Par Value $0.01 per share (NVAX) has 412 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 37,367,414 shares
of 162,190,120 outstanding shares and own 23.04% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (6,796,998 shares), BlackRock Inc. (4,926,789 shares), RA CAPITAL MANAGEMENT, L.P. (2,097,794 shares), STATE STREET CORP (1,746,627 shares), Capital World Investors (1,478,701 shares), FMR LLC (1,461,908 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (1,371,154 shares), FRANKLIN RESOURCES INC (1,072,548 shares), GEODE CAPITAL MANAGEMENT, LLC (956,915 shares), and MORGAN STANLEY (685,624 shares).
This table shows the top 412 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.